|
|
|
Table 2a
Biographical Data, Diagnosis and Therapy for Series II
|
|
Pat.
No.
|
Gender
|
Age
|
Diagnosis
|
Therapy
|
|
10
|
F
|
56
|
Irritated hemarthrosis after implantation of a knee endoprosthesis,
severe Gonarthrosis
|
3 weeks, 1 x daily for 16 mins., Level 3c, NSAR
|
|
11
|
F
|
70
|
Diabetes mellitus, diabetic foot, diabetic Angio-, Neuro-,
and Retinopathy
|
4 weeks, 1 x daily for 16 mins., Level 5, no medication
|
|
12
|
M
|
72
|
Pseudoradicular pain in the entire spinal column
|
3 weeks, 1 x daily for 16 mins., Level 4, NSAR
|
|
13
|
F
|
84
|
Polyarthritis, polyarthrosis
|
4 weeks, 1 x daily for 16 mins., Level 5, NSAR
|
|
15
|
F
|
67
|
Suspicion of loosened endoprosthesis, hip and knee joint
pain
|
4 weeks, 1 x daily for 16 mins., Level 5, NSAR
|
|
16
|
M
|
80
|
Cervical Syndrome,stress-related headaches, lumbar sciaticalgia
due to deg. lumbar spinal column changes
|
4 weeks, 1 x daily for 16 mins., Level 5, no medication
|
|
17
|
F
|
70
|
Chronic cervical syndrome, stress-related headaches, hip
and knee joint complaints, degenerative joint changes
|
3 weeks, 1 x daily for 16 mins., Level 5, NSAR
|
|
18
|
M
|
62
|
Cervical syndrome, shoulder-arm-syndrome (both sides),
acute headache relapses after SHT, Coxalgia
|
3 weeks, 1 x daily for 16 mins., Level 4, no medication
|
|
19
|
F
|
77
|
Massive, degenerative changes of cervical spinal column,
radiation into the occipital region and both arms
|
3 weeks, 1 x daily for 16 mins., Level 5, NSAR
|
|
20
|
M
|
50
|
Cervical syndrome, Epicondylitis, rad. dext. lumbargia
relapses
|
3 weeks, 1 x daily for 16 mins., Level 5, no medication
|
|
21
|
F
|
56
|
Pseudoradicular complaints in cervical and lumbar spinal
column
|
3 weeks, 1 x daily for 16 mins., Level 4, no medication
|
| 22 |
M |
55 |
Pseudoradicular
lumbar spinal column complaints Coxalgia
|
3 weeks, 1 x daily for 16 mins., Level 3c, no medication
|
| 24 |
F |
76 |
Pain
in lumbar spinal column, pelvis-leg region (both sides)
after pubic bone fracture, Osteoporosis |
4 weeks, 1 x daily for 16 mins., Level 5, no medication
|
| 25 |
F |
59 |
Lumbar
Syndrome Relapse |
3 weeks, 1 x daily for 16 mins., Level 5, no medication
|
| 26 |
F |
73 |
Lumbar
Syndrome Relapse |
3 weeks, 1 x daily for 16 mins., Level 3c, no medication
|
| 27 |
F |
66 |
Lumbar
Syndrome Relapse |
3 weeks, 1 x daily for 16 mins., Level 3c, no medication
|
| 28 |
F |
73 |
Selected
diffuse sceletal complaints, include diffus metastasizing
N. Coli |
4 weeks, 1 x daily for 16 mins., Level 5, analgesics
|
|
|
Table 2b
Therapy Success for Series II
|
Pat.
No.
|
D
FBA (cm)
|
Medication
Reduction
|
Therapeutic
Success
|
Remarks
|
| 10 |
N/A |
yes |
Significant
pain reduction, decreasing hemarthrosis, improved mobility |
Initial
NSAR, was reduced to occasional intake after great stress |
| 11 |
N/A |
|
Pain
reduction (feet), reduced secretion from plantar fistulas, partial
healing of small plantar ulcers |
|
| 12 |
-8 |
40-60% |
Significant
pain reduction after only 1 week |
|
| 13 |
N/A |
40-60% |
Improved
mobility and reduced pain in most joints during night sleep
|
|
| 15 |
N/A |
40-60% |
Rapid
improvement of subjective complaints, mobility remained unchanged
|
|
| 16 |
-7 |
|
Improved
mobility |
|
| 17 |
N/A |
yes |
Improved
mobility in cervical spinal column, infrequent headaches, knee
and hip joints more mobile |
|
| 18 |
N/A |
|
Rapid
reduction of arm and hip joint pain, headache relief |
Reduction
of NSAR from daily intake to 1-2 x per week after greater stress |
| 19 |
N/A |
40-60% |
Satisfactory
improvement of arm joint complaints, headache relief |
|
| 20 |
N/A |
|
Satisfactory
improvement of complaints, primarily of cervical spinal column,
later also in elbow region |
|
| 21 |
N/A |
|
Improvement
primarily in lumbar spinal column, later also in cervical spinal
column |
|
| 22 |
-5 |
|
Good
improvement in spinal column symptoms, improved general state
of health |
|
| 24 |
N/A |
|
Good
reduction in pain, significant improvement of general state
of health |
Improved
night sleep already after 1st week of therapy |
| 25 |
-7 |
|
Good
improvement in mobility and pain reduction |
|
| 26 |
-4 |
|
Satisfactory
improvement in mobility, significant pain reduction |
|
| 27 |
-7 |
|
Improved
mobility |
|
| 28 |
N/A |
0 |
Satisfactory
pain reduction, improved mobility using the same analgesic dosage |
Improved
night sleep, significant improvement in general state of health |
Back
to Top
|
|
QRS
Research